Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternate delivery systems for contraceptive progestogens.

K A Ginsburg1, K S Moghissi

  • 1Department of Obstetrics and Gynecology, Wayne State University School of Medicine, C. S. Mott Center for Human Growth and Development, Detroit, Michigan.

Fertility and Sterility
|May 1, 1988
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hormone replacement therapy for menopausal women.

Comprehensive therapy·2000
Same author

A clinician's guide to the use of gonadotropin-releasing hormone analogues in women.

Medscape women's health·2000
Same author

Medical treatment of endometriosis.

Clinical obstetrics and gynecology·1999
Same author

Explicit memory in pregnant women.

American journal of obstetrics and gynecology·1998
Same author

Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis.

Fertility and sterility·1998
Same author

Intensive hormone monitoring in women with unexplained infertility: evidence for subtle abnormalities suggestive of diminished ovarian reserve.

Fertility and sterility·1997
This summary is machine-generated.

Progestin-based contraceptives offer effective, long-acting birth control with fewer side effects than oral methods. Further research is needed to address menstrual irregularities and metabolic changes before widespread approval.

Area of Science:

  • Reproductive endocrinology and pharmacology
  • Contraceptive development and safety evaluation

Background:

  • Development of universally acceptable, safe, and effective female contraceptives is ongoing.
  • Progestational systems, with or without estrogen, are promising candidates.
  • Existing hormonal contraceptives have limitations requiring further research.

Purpose of the Study:

  • To review the contraceptive mechanisms of action of pregnane and 19-nortestosterone progestins.
  • To examine major side effects associated with these progestins, including menstrual abnormalities, metabolic changes, neoplasia, and teratogenicity.
  • To assess the safety profile of progestin-only contraceptives.

Main Methods:

  • Review of existing literature on pregnane and 19-nortestosterone progestins.
Keywords:
BiologyCardiovascular EffectsContraceptionContraceptive Agents, FemaleContraceptive Agents, Progestin--beneficial effectsContraceptive Agents, Progestin--pharmacodynamicsContraceptive Agents, Progestin--side effectsContraceptive Agents--beneficial effectsContraceptive Agents--pharmacodynamicsContraceptive Agents--side effectsCorpus Luteum HormonesDiseasesEconomic FactorsEndocrine SystemEstrogens--side effectsFamily PlanningGenital Effects, FemaleGenitaliaGenitalia, FemaleHormonesLipid Metabolic EffectsLipidsLiterature ReviewMenstruation DisordersMetabolic EffectsPhysiologyProgestational HormonesProgesterone--side effectsReproductive Control AgentsResearch And DevelopmentTechnologyUrogenital EffectsUrogenital System

Related Experiment Videos

  • Analysis of contraceptive efficacy and side effect data.
  • Evaluation of safety data regarding teratogenicity, neoplasia, and systemic effects.

    • Main Results:

    • Progestin-only systems provide highly effective and long-acting contraception.
    • Non-oral administration bypasses gastrointestinal side effects and reduces systemic exposure.
    • Current data suggest no increased risk of fetal malformation, breast cancer, or genital tract cancer.
    • Menstrual abnormalities, hypertension, and adverse lipid alterations remain significant side effects.

    Conclusions:

    • Progestin-based contraceptives are highly effective with a favorable safety profile regarding long-term risks.
    • Further refinement is necessary to mitigate side effects like menstrual irregularities and metabolic disturbances.
    • Continued research is crucial for optimizing progestin contraceptives for general use.